pubmed-article:2529798 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:2529798 | lifeskim:mentions | umls-concept:C0018621 | lld:lifeskim |
pubmed-article:2529798 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:2529798 | lifeskim:mentions | umls-concept:C1696465 | lld:lifeskim |
pubmed-article:2529798 | lifeskim:mentions | umls-concept:C0205195 | lld:lifeskim |
pubmed-article:2529798 | lifeskim:mentions | umls-concept:C0717893 | lld:lifeskim |
pubmed-article:2529798 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:2529798 | pubmed:dateCreated | 1989-11-9 | lld:pubmed |
pubmed-article:2529798 | pubmed:abstractText | Two hundred sixty-four patients with moderate to severe seasonal allergic rhinitis were treated with loratadine 5 mg plus pseudoephedrine 120 mg twice a day or placebo in a 28-day multicenter study. Four nasal and four non-nasal symptoms were evaluated for efficacy. At the last evaluable visit, the active treatment group had significantly lower (P = .05) mean combined nasal and non-nasal symptom scores than the placebo group. Also, the physician's rating of overall therapeutic response was significantly better in the active-treatment group (P = .03). Dry mouth, insomnia, and nervousness were reported by a significantly greater proportion (P less than or equal to .04) in the active-treatment group. Sedation occurred in 7% of patients in each treatment group and 6% of patients in each group discontinued the study because of adverse experiences. Loratadine plus pseudoephedrine was safe and significantly more effective than placebo in relieving the symptoms of allergic rhinitis. | lld:pubmed |
pubmed-article:2529798 | pubmed:language | eng | lld:pubmed |
pubmed-article:2529798 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2529798 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:2529798 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2529798 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2529798 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2529798 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2529798 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2529798 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2529798 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:2529798 | pubmed:month | Oct | lld:pubmed |
pubmed-article:2529798 | pubmed:issn | 0003-4738 | lld:pubmed |
pubmed-article:2529798 | pubmed:author | pubmed-author:SelnerJ CJC | lld:pubmed |
pubmed-article:2529798 | pubmed:author | pubmed-author:GrossmanJJ | lld:pubmed |
pubmed-article:2529798 | pubmed:author | pubmed-author:MossB ABA | lld:pubmed |
pubmed-article:2529798 | pubmed:author | pubmed-author:BronskyE AEA | lld:pubmed |
pubmed-article:2529798 | pubmed:author | pubmed-author:LinzmayerM... | lld:pubmed |
pubmed-article:2529798 | pubmed:author | pubmed-author:LanierB QBQ | lld:pubmed |
pubmed-article:2529798 | pubmed:author | pubmed-author:SchenkelE JEJ | lld:pubmed |
pubmed-article:2529798 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:2529798 | pubmed:volume | 63 | lld:pubmed |
pubmed-article:2529798 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:2529798 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:2529798 | pubmed:pagination | 317-21 | lld:pubmed |
pubmed-article:2529798 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
pubmed-article:2529798 | pubmed:meshHeading | pubmed-meshheading:2529798-... | lld:pubmed |
pubmed-article:2529798 | pubmed:meshHeading | pubmed-meshheading:2529798-... | lld:pubmed |
pubmed-article:2529798 | pubmed:meshHeading | pubmed-meshheading:2529798-... | lld:pubmed |
pubmed-article:2529798 | pubmed:meshHeading | pubmed-meshheading:2529798-... | lld:pubmed |
pubmed-article:2529798 | pubmed:meshHeading | pubmed-meshheading:2529798-... | lld:pubmed |
pubmed-article:2529798 | pubmed:meshHeading | pubmed-meshheading:2529798-... | lld:pubmed |
pubmed-article:2529798 | pubmed:meshHeading | pubmed-meshheading:2529798-... | lld:pubmed |
pubmed-article:2529798 | pubmed:meshHeading | pubmed-meshheading:2529798-... | lld:pubmed |
pubmed-article:2529798 | pubmed:meshHeading | pubmed-meshheading:2529798-... | lld:pubmed |
pubmed-article:2529798 | pubmed:meshHeading | pubmed-meshheading:2529798-... | lld:pubmed |
pubmed-article:2529798 | pubmed:meshHeading | pubmed-meshheading:2529798-... | lld:pubmed |
pubmed-article:2529798 | pubmed:meshHeading | pubmed-meshheading:2529798-... | lld:pubmed |
pubmed-article:2529798 | pubmed:meshHeading | pubmed-meshheading:2529798-... | lld:pubmed |
pubmed-article:2529798 | pubmed:meshHeading | pubmed-meshheading:2529798-... | lld:pubmed |
pubmed-article:2529798 | pubmed:meshHeading | pubmed-meshheading:2529798-... | lld:pubmed |
pubmed-article:2529798 | pubmed:meshHeading | pubmed-meshheading:2529798-... | lld:pubmed |
pubmed-article:2529798 | pubmed:meshHeading | pubmed-meshheading:2529798-... | lld:pubmed |
pubmed-article:2529798 | pubmed:year | 1989 | lld:pubmed |
pubmed-article:2529798 | pubmed:articleTitle | Loratadine-pseudoephedrine combination versus placebo in patients with seasonal allergic rhinitis. | lld:pubmed |
pubmed-article:2529798 | pubmed:affiliation | Allergy Division, Albany Medical College, New York. | lld:pubmed |
pubmed-article:2529798 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:2529798 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:2529798 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:2529798 | pubmed:publicationType | Multicenter Study | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2529798 | lld:pubmed |